Composition-of-matter and method-of-use
Defensible IP, licensable on terms.
Motark partners with counterparties to take promising compounds from characterisation through to defensible IP — composition-of-matter and method-of-use patenting where applicable, formulation IP, and trade-secret extraction protocols.
PROGRAMMES
COMPOUNDS
ACCESS
TERRITORY
01 · Portfolio
Four categories of licensable asset.
The Motark IP register sits across four asset types. Each is structured for defensibility at the counterparty's downstream regulatory and commercial layer.
Composition-of-matter
Novel compositions, standardised extract specifications, and proprietary fraction ratios filed where the composition itself is the inventive step.
Method-of-use
Specific therapeutic, functional, or formulation use cases where the application of a known compound or extract is the inventive step.
Formulation IP
Combination products, delivery-system pairings, and stability-optimised formulations where the formulation engineering carries the value.
Trade-secret protocols
Proprietary extraction, fractionation, and standardisation protocols held as trade secrets — licensable under explicit confidentiality framework.
02 · Engagement
Proprietary compositions, under licence.
Motark licenses proprietary compositions, standardised extract specifications, method-of-use IP, and formulation engineering to pharmaceutical, nutraceutical, and regulated-wellness counterparties. Each licensable asset sits in one of the four register categories above.
Counterparties engage through verified review under NDA. Portfolio detail is not published.
03 · Commercial framework
Terms, briefly.
Outline of the typical licensing framework. Final terms are negotiated per asset, counterparty, and indication.
- Counterparty profile
- Pharmaceutical and nutraceutical manufacturers, regulated wellness brands, ingredient distributors with downstream brand relationships.
- Geography
- Per-jurisdiction or worldwide licences, with exclusivity tiered by territory, channel, and indication where applicable.
- Exclusivity
- Exclusive, co-exclusive, and non-exclusive structures depending on the asset and the counterparty's commitment profile.
- Commercial structure
- Upfront, milestone, royalty, or hybrid structures. Material-supply terms negotiated separately or bundled.
- Term and termination
- Term aligned to commercial life of the asset. Termination triggers, milestone gates, and reversion clauses negotiated.
Verified counterparties
Start a licensing conversation.
Pharmaceutical, nutraceutical, and regulated-wellness counterparties: tell us the indication, the market, and the framework you're working in, and we'll route the right person from the IP team.